title: Cellular reprogramming for understanding and treating human disease.
abstract: In the last two decades we have witnessed a paradigm shift in our understanding of cells so radical that it has rewritten the rules of biology. The study of cellular reprogramming has gone from little more than a hypothesis, to applied bioengineering, with the creation of a variety of important cell types. By way of metaphor, we can compare the discovery of reprogramming with the archeological discovery of the Rosetta stone. This stone slab made possible the initial decipherment of Egyptian hieroglyphics because it allowed us to see this language in a way that was previously impossible. We propose that cellular reprogramming will have an equally profound impact on understanding and curing human disease, because it allows us to perceive and study molecular biological processes such as differentiation, epigenetics, and chromatin in ways that were likewise previously impossible. Stem cells could be called "cellular Rosetta stones" because they allow also us to perceive the connections between development, disease, cancer, aging, and regeneration in novel ways. Here we present a comprehensive historical review of stem cells and cellular reprogramming, and illustrate the developing synergy between many previously unconnected fields. We show how stem cells can be used to create in vitro models of human disease and provide examples of how reprogramming is being used to study and treat such diverse diseases as cancer, aging, and accelerated aging syndromes, infectious diseases such as AIDS, and epigenetic diseases such as polycystic ovary syndrome. While the technology of reprogramming is being developed and refined there have also been significant ongoing developments in other complementary technologies such as gene editing, progenitor cell production, and tissue engineering. These technologies are the foundations of what is becoming a fully-functional field of regenerative medicine and are converging to a point that will allow us to treat almost any disease.
authors.affiliation: Epigenetics Laboratory, Department of Anatomy, Howard University Washington, DC, USA.
authors.forename: Riya R
authors.initials: RR
authors.lastname: Kanherkar
authors.affiliation: Epigenetics Laboratory, Department of Anatomy, Howard University Washington, DC, USA.
authors.forename: Naina
authors.initials: N
authors.lastname: Bhatia-Dey
authors.affiliation: InSilico Medicine, Emerging Technology Center, Johns Hopkins University Eastern Baltimore, MD, USA.
authors.forename: Evgeny
authors.initials: E
authors.lastname: Makarev
authors.affiliation: Epigenetics Laboratory, Department of Anatomy, Howard University Washington, DC, USA.
authors.forename: Antonei B
authors.initials: AB
authors.lastname: Csoka
keywords: aging; disease; epigenetics; reprogramming; stem cells